Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
183,255,226
-
Number of holders
-
175
-
Total 13F shares, excl. options
-
91,435,188
-
Shares change
-
-2,343,064
-
Total reported value, excl. options
-
$1,691,767,958
-
Value change
-
-$43,730,310
-
Put/Call ratio
-
74%
-
Number of buys
-
98
-
Number of sells
-
59
-
Price
-
$18.50
Institutional Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q3 2019
As of 30 Sep 2019 HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) had 217 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 91,435,188 shares of stock of the company.
Largest 10 holders included FRANKLIN RESOURCES INC, FMR LLC, VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, TANG CAPITAL MANAGEMENT LLC, JANUS HENDERSON GROUP PLC, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, ArrowMark Colorado Holdings LLC, and Clearbridge Investments, LLC.
This table shows 217 institutional shareholders of the security as of 30 Sep 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.